| Description | Romlusevimab (BRII-198) is a human IgG1 monoclonal antibody that neutralizes the SARS-CoV-2 spike protein, effectively targeting the virus responsible for severe acute respiratory syndrome [1] [2]. |
| molecular weight | N/A |
| CAS | 2509447-08-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years | Shipping with blue ice. |